This is a robopost that was scheduled a year ago for January 24, 2013.
One year ago today:
Roswell Park Cancer Institute held a press conference this morning to announce the development of an investigational cancer vaccine.
Officials from Roswell were on hand to highlight what the vaccine can do. They say the NY-ESO-1 dendritic cell vaccine has the potential to “eradicate cancer cells and prevent disease relapse.”
The new NY-ESO-1 dendritic cell vaccine is expected to show great promise in patients with bladder, brain, breast, esophageal, gastrointestinal, hepatocellular, kidney, lung, melanoma, ovarian, prostate, sarcoma and uterine tumors.
It will be interesting to see if announcements of success have been made.
Update: What I hadn’t counted on a year ago when scheduling this post is that the link to the article would be dead!
Second update: Original source is Roswell Park Launches Landmark Immunotherapy Vaccine Trial